Skip to content

A verification study of safety and effects of the consumption of Beverage of Fermented Plant Extract SW containing low-molecular-weight collagen on making skin lighter and more beautiful in healthy Japanese women: an open-label trial

A verification study of safety and effects of the consumption of Beverage of Fermented Plant Extract SW containing low-molecular-weight collagen on making skin lighter and more beautiful in healthy Japanese women: an open-label trial - A verification study of making lighter and more beautiful skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032658
Enrollment
29
Registered
2018-05-21
Start date
2018-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 12 weeks Test beverage: Beverage of Fermented Plant Extract SW containing low-molecular-weight collagen Administration: Drink a cup of the beverage with an attached dosing cup (20 mL) once

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Hiroo Dermatology Clinic &amp
Collaborator
Mentors inc. Faculty of Human Sciences, Waseda University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Japanese women ages 30 years and up who are dissatisfied with their skin 2. Subjects who are judged as eligible to participate in the study by the physician. 3. Within the subjects who met the 2nd inclusion criteria, subjects whose facial melanin concentrations are relatively high as evaluated by Mexameter

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history or under the treatment of malignant tumor, heart failure, or myocardial infarction 2. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver failure, kidney failure, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or any other chronic diseases 3. Subjects who use or take "FOSHU", "Foods with Functional Claims", or other functional food/beverage daily 4. Subjects who have been diagnosed with atopic dermatitis 5. Subjects who are undergoing medical treatment for dryness or inflammation of their skin by a dermatologist, or are difficult to test because of a wound on the measurement part of the skin 6. Subjects who use any other products except for general skin care products (a cream/essence, a skin pack, skin lotion, milky lotion, sunscreen, and these all-in-one products) 7. Subjects who regularly receive skin care treatment (massages etc.) or use beauty products (facial equipment etc.) 8. Subjects who have changed their makeup habits within the last three months, or are going to change their makeup habits during this trial (from the agreement to participate in this trial to the final test) 9. Subjects who have been overexposed to the sun within the last month, or are going to be overexpose to the sun during this trial (from the agreement to participate in this trial to the final test) 10. Subjects who are currently taking medications (including herbal medicines) and supplements 11. Subjects who are allergic to soybeans, apple, banana, peach, kiwi fruit, Japanese yam, sesame seeds, gelatin, medicines, and/or the test beverage related products 12. Subjects who are pregnant, breast-feeding, or plan to become pregnant 13. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 14. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

MeasureTime frame
Melanin concentrations on facial skin * Quantify the facial melanin concentrations by Mexameter * Perform the test at screening and examination before consumption and at 12 weeks after consumption

Secondary

MeasureTime frame
1. Erythema concentrations on facial skin 2. Doctor observations tone of the skin 3. Skin assessment 4. Subjective symptoms (the Likert scale) 5. Blood test high-sensitivity CRP level *1 Quantify and evaluate the redness of erythema on the facial skin by Mexameter *2 Each item was assessed with a five-point grading scale from 1 (marked improvement) to 5 (deterioration). The smaller number indicates better skin condition *3 Quantify and evaluate facial pigmentations, wrinkles, skin texture, pores, skin tone, and redness by Robo Skin Analyzer *4 Each item was assessed with a six-point grading scale from 1 (strongly agree) to 6 (strongly disagree). The smaller number indicates better skin condition *1-5 Perform these tests at screening and examination before consumption and at 12 weeks after consumption

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026